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ABSTRACT
Objectives To conduct an independent evaluation of the
first phase of the Health Foundation’s Safer Patients
Initiative (SPI), and to identify the net additional effect of
SPI and any differences in changes in participating and
non-participating NHS hospitals.
DesignMixed method evaluation involving five
substudies, before and after design.
Setting NHS hospitals in United Kingdom.
Participants Four hospitals (one in each country in the UK)
participating in the first phase of the SPI (SPI1); 18 control
hospitals.
Intervention The SPI1 was a compound (multi-
component) organisational intervention delivered over
18 months that focused on improving the reliability of
specific frontline care processes in designated clinical
specialties and promoting organisational and cultural
change.
Results Senior staff members were knowledgeable and
enthusiastic about SPI1. There was a small (0.08 points
on a 5 point scale) but significant (P<0.01) effect in favour
of the SPI1 hospitals in one of 11 dimensions of the staff
questionnaire (organisational climate). Qualitative
evidence showed only modest penetration of SPI1 at
medical ward level. Although SPI1 was designed to
engage staff from the bottomup, it did not usually feel like
this to those working on the wards, and questions about
legitimacy of some aspects of SPI1were raised. Of the five
components to identify patients at risk of deterioration—
monitoring of vital signs (14 items); routine tests (three
items); evidence based standards specific to certain
diseases (three items); prescribing errors (multiple items
from the British National Formulary); and medical history
taking (11 items)—there was little net difference between
control and SPI1 hospitals, except in relation to quality of
monitoring of acute medical patients, which improved on
average over time across all hospitals. Recording of
respiratory rate increased to a greater degree in SPI1 than
in control hospitals; in the second six hours after
admission recording increased from 40% (93) to 69%
(165) in control hospitals and from 37% (141) to 78%
(296) in SPI1 hospitals (odds ratio for “difference in
difference” 2.1, 99% confidence interval 1.0 to 4.3;
P=0.008). Use of a formal scoring system for patients with
pneumonia also increased over time (from 2% (102) to
23% (111) in control hospitals and from 2% (170) to 9%
(189) in SPI1 hospitals), which favoured controls and was
not significant (0.3, 0.02 to 3.4; P=0.173). There were no
improvements in the proportion of prescription errors and
no effects that could be attributed to SPI1 in non-targeted
generic areas (such as enhanced safety culture). On some
measures, the lack of effect could be because compliance
was already high at baseline (such as use of steroids in
over 85% of cases where indicated), but even when there
was more room for improvement (such as in quality of
medical history taking), there was no significant
additional net effect of SPI1. There were no changes over
time or between control and SPI1 hospitals in errors or
rates of adverse events in patients in medical wards.
Mortality increased from 11% (27) to 16% (39) among
controls anddecreased from17% (63) to 13% (49) among
SPI1 hospitals, but the risk adjusted difference was not
significant (0.5, 0.2 to 1.4; P=0.085). Poor care was a
contributing factor in four of the 178 deaths identified by
review of case notes. The survey of patients showed no
significant differences apart from an increase in
perception of cleanliness in favour of SPI1 hospitals.
Conclusions The introduction of SPI1was associatedwith
improvements in one of the types of clinical process
studied (monitoring of vital signs) and one measure of
staff perceptions of organisational climate. There was no
additional effect of SPI1 on other targeted issues nor on
other measures of generic organisational strengthening.
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INTRODUCTION
Since the publication of two key reports in 2000,1 2
increased efforts, attention, and resources have been
given to patient safety, but by 2005 progress was
reported as frustratingly slow.3 There is now keen
interest in finding ways to make more sustained
improvements. Approaches to patient safety that aim
to intervene at an organisational level and that actively
engage workers in the management of risk are argued
to be especially promising for providing solutions to
the problems of patient safety.4 5 The Health Founda-
tion’s Safer Patients Initiative (SPI) was an important
example of such an approach.
The Safer Patients Initiative programme
TheHealthFoundation selected four hospitals (table1),
one in each country of the United Kingdom, to partici-
pate in the first phase of SPI (SPI1). 6 The Health Foun-
dation (a British charity dedicated to improving the
quality of healthcare) invested £775 000 (€900 000,
$1.2m) in each hospital. SPI1 ran from January 2005
to September 2006 inclusive and was intended to
embed and spread thereafter. The Health Foundation
issued a request for applications to conduct an indepen-
dent evaluation of the SPI1 intervention.We report on
the results of this evaluation.
SPI1 set out to secure improvements in patient
safety7-9 and covered a range of aims (box 1), which
included a 50% reduction in adverse events.10 Men-
tored by the Institute for Healthcare Improvement
(IHI), based in theUnited States, it had several features
similar to the well publicised US “Saving 100,000 lives
campaign.”11 12 The intervention consisted of many
components (box 1), some generic (aimed at strength-
ening the organisation as a whole) and others targeted
at specific high risk clinical issues. The generic compo-
nents sought to promote patient safety as an organisa-
tional priority, increase the effectiveness of senior
leadership in relation to safety, engender a culture of
safety, and instil knowledge of the principles of safe
practice among staff. The targeted components of
SPI1 focused on improving the reliability of specific
frontline care processes in designated clinical areas
(general wards, critical care, perioperative care, and
management of medicines).
From each hospital, 15-20 “change agents” partici-
pated in four learning sessions run by the IHI to gain
knowledge and expertise in how to change practice,
measure the effects, and sustain safety
improvements.7-9 Change agents were charged with
leading change by facilitating the implementation of
SPI1 in their hospitals. They also formed a virtual com-
munity that shared data, tools, expertise, and experi-
ence; participated in conference calls and electronic
mailing lists; and uploaded monthly progress reports
through a project intranet.
SPI1 hospitals received site visits and technical assis-
tance from the IHI over the course of the programme,
and staff members in participating hospitals were
asked to take part in surveys of safety culture managed
by the IHI. Changes in clinical processes were sup-
ported by learning materials (such as care “bundles,”
collections of carefully packaged evidence based stan-
dards directed at a particular condition or clinical sce-
nario) (box 1). The intention was to encourage
compliance with the tenets of safe and effective care
by using Plan-Do-Study-Act (PDSA) cycles, where
changes are first implemented on a small scale and
tested and refined before being rolled out on a larger
scale. The programme strongly emphasised the role of
measurement in improving patient safety. Staff mem-
bers were expected to upload time series process data
(such as compliance with prophylaxis for deep vein
thrombosis) to the project intranet to create run
charts—graphs to help people visualise changes on
selected measures over time. Monitoring of care pro-
cesses through these charts was seen as important for
guiding local improvement activities and evaluating
their impact.
Study aims
Weevaluated changes in a range of end points relevant
to patient safety over time and whether these changes
could be attributed to SPI1 in the four participating
hospitals. We used a controlled design to identify
whether SPI1 had any additional effect (that is, net of
any overall trends in hospital safety over the same per-
iod).
We have reported here on themethods used and the
main findings based on SQUIRE guidelines.13 Further
details are available in the full online report.6 The eva-
luation of the rollout of SPI to other hospitals (SPI2) is
available in a companion paper.14
METHODS
Framework for evaluation
The study was a “mixed method” evaluation1516
because it combined qualitative and quantitative data
and involved many “levels” in the organisation, “from
boardroom to patient.”15-19 This type of evaluation is
particularly suitable for service delivery/management
interventions that are not likely to yield the type of con-
clusive results characteristic of evaluations of treat-
ments based on measurement of outcomes on
patients.20 Mixed method evaluation draws on the
idea of “triangulation,” where confidence in the find-
ings increases when observations of one type are cor-
roborated by other types of evidence. This follows a
tradition in the philosophy of science.15-19 Figure 1
shows the framework for the evaluation.
Table 1 | NHS hospitals* that participated in phase one of Safer Patients Initiative (SPI1)
Hospital
number
Rural/
urban Noofbeds Teaching status A and E ICU
FTE consultant
(specialists)
1 Urban 625 Associate teaching hospital Yes Yes 112
2 Rural 750 No Yes Yes 120
3 Urban 903 Principal teaching hospital Yes Yes 242
4 Rural 280 No Yes No 36
A and E=accident and emergency department; FTE=full time equivalent; ICU=intensive care unit.
*National Health Service hospital, with no private beds. Figures provided as of October 2004.
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Substudies
The evaluation comprised five substudies to investi-
gate key aims of the initiative (table 2).
Improvement of leadership and engagement of leaders and
staff—Semistructured interviews were conducted to
assess knowledge and enthusiasm for the initiative
among 60 seniormembers of staff in the four SPI1 hos-
pitals.
Improvement in culture of safety and “transformative”
effects—Before and after surveys of staff attitudes in con-
trol and SPI1 hospitals were conducted by means of a
validatedquestionnaire to assess staffmorale, attitudes,
and aspects of culture (theNHSNational Staff Survey).
Informing, educating, and motivating frontline clinical
staff—Qualitative studies comprising ethnographic
observations on acute medical wards, interviews, and
focus groups in SPI1 hospitals were conducted to
obtain direct access to staff behaviour and views, and
to add depth of understanding.
Impact on processes of clinical care—To identify any
improvements, we measured error rates in control
and SPI1 hospitals by means of explicit (criterion
based) and separate holistic reviews of case notes.
The study group comprised patients aged 65 or over
who had been admitted with acute respiratory disease:
this is a high risk group to whommany evidence based
guidelines apply and hence where significant effects
were plausible.
Improving outcomes of care—Wereviewed case notes to
identify adverse events andmortality and assessed any
improvement in patients’ experiences by using a vali-
dated measure of patients’ satisfaction (the NHS
patient survey).
Study sample
Data were collected in the four SPI1 intervention hos-
pitals and 18 control hospitals. For economy, the con-
trol hospitals comprised nine that would later
participate in the second phase of SPI (SPI2) but were
pre-intervention at the timeof this study.A further nine
controls were added that would also form the controls
for the SPI2 hospitals.14 All 18 control hospitals were
located in England (thereby providing access to the
NHS staff and patient surveys).
Use of before and after observations across control
and SPI1 sites enabled us to compare rates of change
across control and SPI1 hospitals over time. This
approach, known as the “difference in difference”
method,18 is particularly suitable for identifying tem-
poral variations in outcomes that are not due to expo-
sure to the intervention that is being evaluated, and is
used to take into account the effect of events other than
the particular intervention of interest that occur over
the intervention period.
Interviews with strategic/senior staff
Using semistructured telephone interviews with 60
hospital staff members in strategic/senior positions
across the four hospitals, we investigated how far
participants understood and expressed enthusiasm
for the SPI1. A researcher (JW, see acknowledgments)
Box 1: Key generic and specific elements of the Safer Patients Initiative
General aim: “to avoid unnecessary harm, pain or suffering as a result of error in medical
interventions”
Generic improvement to reduce adverse events
Aims
 Build a culture of safety and good leadership
 Train to enable organisations to identify problems and develop and evaluate methods
to reduce risk
 Foster an understanding of the principles of safe practice
Approach used in SPI
 Collaborative residential learning sessions with the Institute for Healthcare Improvement
(IHI) faculty to train “change agents”who would lead implementation in their hospitals
 Instruction in use of control charts
 Web based learning and site visits from IHI expert faculty
 Know-how for Plan-Do-Study-Act (PDSA) cycles
 Electronic facility for information sharing—for example, to share results of PDSA cycles
 Leadership projected in part by management walk rounds
 Participation in safety culture surveys
 Formation of a collaborative learning community
Specific interventions
Aim
 Identify and respond to deteriorating patients to reduce need for “crash calls” and
avoidable mortality
Approach used in SPI
 Review of 50 deaths carried out by hospital staff
 Tools for monitoring patients’ condition and for triggering action, such as forms to
record vital signs and other salient information (such as early warning score system
(EWSS))
 Promote the use of risk (severity) scores
 Establish a rapid response team
Aim
 Reduce medication errors
Approach used in SPI
 Assessment of medication safety by involving staff in failure mode effects analysis
(FMEA); educating staff to identify and remedy weak links in medication practice from
prescribing to administration and monitoring
 Tool to identify and measure rates of adverse events
 Tool to reduce adverse events from treatment with anticoagulants
 Education to improve “medicine reconciliation,” to ensure that medicines that patients
were taking before admissionwere not inadvertently omitted or altered after admission
Aim
 Communication between staff to reduce adverse events/mortality
Approach used in SPI
 Situation background assessment recommendation (SBAR) tool to ensure that
information is communicated in a structured way
 Safety briefings; briefings at shift changes to ensure staff members are aware of
relevant information for patients
Aim
 Infection control including for meticillin resistant Staphylococcus aureus (MRSA)
Approach used in SPI
 Perioperative antibiotics to reduce infection at surgical site
 Catheter insertion and maintenance drill to prevent central line infections in intensive
care
 Following the tenets of a package of ventilator guidelines (bundles) to reduce ventilator
acquired pneumonia, venous thromboembolism, and stress ulcers in intensive care units
 Improvements in hand hygiene—for example, by training and use of posters
RESEARCH
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conducted the interviews, which were tape recorded
and transcribed. Data analysis was first based on the
constant comparative method that was used to gener-
ate thematic categories into which participants’
accounts could be categorised.21 Three independent
reviewers then scored the responses of hospital partici-
pants on a 1-10 scale for level of knowledge and level of
enthusiasm.
Staff survey
The National NHS Staff Survey questionnaire was
used at two time points to measure variables such as
staff morale, attitudes, and aspects of “culture” that
might be affected by the generic strengthening of orga-
nisational systems that SPI1 intended to achieve. Ele-
ven of the 28 survey questions (table 3)22-26 were
identified as likely to be of relevance. Questionnaires
were sent to all staff members in the four SPI1 hospi-
tals, including the three hospitals outside England that
did not routinely participate in the National NHS Staff
Survey. In each of the 18 control hospitals, a simple
random sample of 850 staff members was used; at this
sample size, an average 60% response rate would yield
95% confidence intervals of no greater than 10% for all
scores in a single organisation. Further detail about the
questionnaire is available from www.nhsstaffsurveys.
com, and further detail about the evaluation is in the
full report. 6 Statistical analyses were adjusted for age,
sex, ethnic background, occupational group, length of
service, and management status.
Qualitative study
One author (AS) undertook three rounds of data col-
lection. Between April and September 2006, she vis-
ited one medical ward in each of the four hospitals for
one week. She undertook around 150 hours of ethno-
graphic observations and 47 interviews with different
types of ward staff, focusing on general issues relating
to patient safety and SPI1. The wards were selected on
the basis that they would treat many of the patients
whose case notes would be reviewed (see below), but
not on the basis that SPI1 “change agents” (see box 1)
were necessarily active on these wards. From April to
June 2007, shortly after the intervention phase, a sec-
ond week-long visit to each ward involved a further
round of ethnographic observations (around 150
hours) and 41 interviews. A third visit involving three
focus groups at each site (one at study ward level, one
involving people with responsibilities for patient
safety/SPI1, and one at strategic level) was used to
feed back preliminary findings and to ask staff for
their reflections on SPI1. These were carried out in
Intervention Level
Meta level (NHS policy
background/type of hospital)
Evaluation
Meso level
(management)
Generic aspects of SPI
for example, improving
leadership, education on
principles of safety science
Intervening variables
Senior staff interviews
(substudy 1)
General staff questionnaires
(substudy 2)
Micro level
(clinical care)
Adverse events,
mortality, satisfaction
(substudy 5)
Patient outcomes
Specific aspects of SPI
for example, early warning
tools, “bundles” of guidelines
Ethnographic
observations on wards
(substudy 3)
Quantification of error rates
(substudy 4)
Fig 1 | General scheme for evaluation of first phase of Safer Patients Initiative
Table 2 | Summary of substudies comprising evaluation of phase one of Safer Patients Initiative (SPI1)
Substudy and topic Data source Location
Unit of analysis
(quantitative studies)
Interviews with senior staff
Impact of SPI at senior management level Semistructured interviews with senior
hospital staff
SPI1 hospitals NA
Staff survey
Staff morale, culture, and opinion Questionnaire as used in NHS National
Staff Survey
Control and SPI1 hospitals Staff member
Qualitative study
Impact of SPI on practitioners at ward level Ethnographic observations, interviews,
and focus groups in acute medical
wards
SPI1 hospitals NA
Quality of care: acute medical care
Quality of care of patients aged >65 with acute
respiratory disease
Case note reviews (both explicit and
holistic)
Control and SPI1 hospitals Patient
Outcomes
Adverse events in patients aged >65 with acute
respiratory disease
Holistic case note review Control and SPI1 hospitals Patient
Hospital mortality in patients aged >65 with acute
respiratory disease
Case note review Control and SPI1 hospitals Patient
Patient satisfaction Questionnaire as used in NHS patient
surveys
Control and SPI1 hospitals Hospital
NA=not applicable.
RESEARCH
page 4 of 14 BMJ | ONLINE FIRST | bmj.com
Ta
bl
e
3
|S
ta
ff
su
rv
ey
sc
o
re
s
in
co
n
tr
o
l
a
n
d
S
P
I1
h
o
sp
it
a
ls
a
t
tw
o
p
e
ri
o
d
s*
in
e
va
lu
a
ti
o
n
o
f
p
h
a
se
o
n
e
o
f
S
a
fe
r
P
at
ie
n
ts
In
it
ia
ti
ve
(S
P
I1
)
S
u
rv
e
y
q
u
e
st
io
n
‡
C
o
n
tr
o
lh
o
sp
it
a
ls
S
P
I1
h
o
sp
it
a
ls
R
a
n
g
e
a
t
b
a
se
li
n
e
§
Ef
fe
ct
o
f
S
P
I1
(9
9
%
C
I)
¶,
P
va
lu
e
P
o
in
t
e
st
im
a
te
fa
vo
u
rs
S
P
I1
S
u
rv
ey
1
S
u
rv
ey
2
†
A
b
so
lu
te
%
ch
a
n
g
e
S
u
rv
ey
1
S
u
rv
ey
2
†
A
b
so
lu
te
%
ch
a
n
g
e
N
o
o
f
re
sp
o
n
d
e
rs
S
co
re
(S
E)
N
o
o
f
re
sp
o
n
d
e
rs
S
co
re
(S
E)
N
o
o
f
re
sp
o
n
d
e
rs
S
co
re
(S
E)
N
o
o
f
re
sp
o
n
d
e
rs
S
co
re
(S
E)
W
el
ls
tr
u
ct
u
re
d
a
p
p
ra
is
a
ls
w
it
h
in
p
re
vi
o
u
s
1
2
m
o
n
th
s2
2
2
3
8
0
4
6
3
9
(1
)
7
2
6
0
2
8
(1
)
−1
0
6
1
1
1
3
4
(1
)
3
9
9
3
2
7
(1
)
−7
2
7
-4
6
3
(−
2
to
8
),
0
.0
9
5
Ye
s
W
o
rk
in
g
in
w
e
ll
st
ru
ct
u
re
d
te
a
m
s2
4
8
0
5
2
4
0
(1
)
7
2
7
9
3
7
(1
)
−3
6
0
8
8
3
8
(1
)
3
9
6
1
3
5
(1
)
−2
3
4
-5
2
1
(−
4
to
6
),
0
.5
1
0
Ye
s
W
it
n
es
se
d
p
o
te
n
ti
a
lly
h
a
rm
fu
le
rr
o
rs
o
r
n
ea
r
m
is
se
s
in
p
re
vi
o
u
s
m
o
n
th
8
2
3
6
4
7
(1
)
7
5
2
0
3
9
(1
)
−8
6
2
4
2
4
8
(1
)
4
1
3
3
4
4
(1
)
−4
4
1
-5
6
5
(−
2
to
1
1
),
0
.0
6
8
N
o
W
o
rk
re
la
te
d
in
ju
ry
in
p
re
vi
o
u
s
1
2
m
o
n
th
s
8
2
8
6
2
2
(0
)
7
3
7
2
1
9
(0
)
−3
6
2
4
6
2
1
(1
)
4
0
2
3
1
8
(1
)
−3
1
8
-2
6
0
(−
4
to
3
),
0
.8
5
4
N
A
W
o
rk
re
la
te
d
st
re
ss
in
p
re
vi
o
u
s
1
2
m
o
n
th
s
8
3
6
8
3
4
(1
)
7
4
5
7
3
3
(1
)
−1
6
3
4
0
3
4
(1
)
4
0
9
4
3
0
(1
)
−4
2
9
-3
9
−5
(−
1
2
to
0
),
0
.0
1
3
Ye
s
P
h
ys
ic
a
lv
io
le
n
ce
fr
o
m
p
a
ti
en
ts
/
re
la
ti
ve
s
in
p
re
vi
o
u
s
1
2
m
o
n
th
s
8
2
8
3
1
3
(0
)
7
4
8
2
1
1
(0
)
−2
6
2
9
0
1
5
(0
)
4
1
1
7
1
1
(0
)
−3
9
-1
8
−3
(−
8
to
0
),
0
.0
2
6
Ye
s
In
te
n
ti
o
n
to
le
a
ve
2
5
8
2
6
3
3
.3
6
(0
.0
1
)
7
4
3
7
3
.2
9
(0
.0
1
)
−0
.0
8
6
2
8
2
3
.2
9
(0
.0
1
)
4
1
1
1
3
.2
1
(0
.0
1
)
−0
.0
9
2
.9
9
-3
.5
1
0
.0
4
(−
0
.0
3
to
0
.1
0
),
0
.1
3
9
N
o
S
ta
ff
jo
b
sa
ti
sf
a
ct
io
n
2
5
8
3
5
7
3
.4
7
(0
.0
1
)
7
4
9
5
3
.3
7
(0
.0
1
)
−0
.1
0
6
3
6
6
3
.4
2
(0
.0
1
)
4
1
2
2
3
.3
4
(0
.0
1
)
−0
.0
9
3
.2
5
-3
.5
7
0
.0
3
(−
0
.0
2
to
0
.0
8
),
0
.1
3
2
Ye
s
Q
u
a
li
ty
o
f
w
o
rk
-l
if
e
b
a
la
n
ce
2
5
8
2
4
9
2
.6
3
(0
.0
1
)
7
4
3
6
2
.7
2
(0
.0
1
)
0
.1
0
6
3
3
0
2
.6
1
(0
.0
1
)
4
1
0
6
2
.6
7
(0
.0
2
)
0
.0
6
2
.4
5
-2
.8
0
−0
.0
5
( −
0
.1
2
to
0
.0
3
),
0
.1
0
6
N
o
S
u
p
p
o
rt
fr
o
m
su
p
e
rv
is
o
rs
2
5
8
3
1
0
3
.4
5
(0
.0
1
)
7
4
7
7
3
.4
1
(0
.0
1
)
−0
.0
5
6
3
3
4
3
.3
6
(0
.0
1
)
4
1
0
9
3
.3
2
(0
.0
1
)
−0
.0
4
3
.1
8
-3
.5
5
0
.0
2
(−
0
.0
4
to
0
.0
8
)
0
.3
5
8
Ye
s
O
rg
a
n
is
a
ti
o
n
a
lc
li
m
a
te
2
5
2
6
8
3
0
2
3
.1
1
(0
.0
1
)
7
4
2
4
2
.8
9
(0
.0
1
)
−0
.2
2
6
2
6
7
3
.0
8
(0
.0
1
)
4
0
7
0
2
.9
3
(0
.0
1
)
−0
.1
5
2
.8
2
-3
.3
2
0
.0
8
(0
.0
2
to
0
.1
3
),
<0
.0
1
Ye
s
N
A
=n
o
t
a
p
p
li
ca
b
le
.
*S
u
rv
e
y
p
e
ri
o
d
s
d
o
n
o
t
m
a
p
p
re
ci
se
ly
to
e
p
o
ch
s
d
e
sc
ri
b
e
d
in
m
e
th
o
d
s
se
ct
io
n
.
†
A
ft
e
r
in
te
rv
e
n
ti
o
n
.
‡
Fi
rs
t
si
x
sc
o
re
s
a
re
p
e
rc
e
n
ta
g
e
s,
si
m
p
ly
re
fl
e
ct
in
g
p
ro
p
o
rt
io
n
o
f
re
sp
o
n
d
e
n
ts
w
h
o
a
n
sw
e
re
d
“y
e
s”
to
si
n
g
le
q
u
e
st
io
n
o
r
se
t
o
f
q
u
e
st
io
n
s.
Th
e
fi
ve
o
th
e
rs
a
re
o
n
sc
a
le
o
f
1
-5
a
n
d
a
re
b
a
se
d
o
n
m
e
a
n
o
f
b
e
tw
e
e
n
th
re
e
a
n
d
si
x
q
u
e
st
io
n
s,
e
a
ch
o
f
w
h
ic
h
w
a
s
sc
o
re
d
b
e
tw
e
e
n
1
a
n
d
5
fo
r
e
a
ch
re
sp
o
n
d
e
n
t.
Fo
r
fo
u
r
o
f
th
e
se
fi
ve
sc
o
re
s
(q
u
a
li
ty
o
f
w
o
rk
-l
if
e
b
a
la
n
ce
,
st
a
ff
jo
b
sa
ti
sf
a
ct
io
n
,
su
p
p
o
rt
fr
o
m
su
p
e
rv
is
o
rs
,
a
n
d
o
rg
a
n
is
a
ti
o
n
a
l
cl
im
a
te
),
h
ig
h
e
r
sc
o
re
s
a
re
b
e
tt
e
r,
e
xc
e
p
t
fo
r
in
te
n
ti
o
n
to
le
a
ve
.
§I
n
d
ic
a
te
s
ra
n
g
e
o
f
sc
o
re
s
a
cr
o
ss
in
te
rv
e
n
ti
o
n
a
n
d
co
n
tr
o
l
h
o
sp
it
a
ls
in
fi
rs
t
su
rv
e
y
to
g
iv
e
so
m
e
co
n
te
xt
fo
r
le
ve
l
o
f
ch
a
n
g
e
sh
o
w
n
.
D
if
fe
re
n
ce
in
ch
a
n
g
e
a
n
d
co
rr
e
sp
o
n
d
in
g
co
n
fi
d
e
n
ce
in
te
rv
a
l
d
o
e
s
n
o
t
n
e
ce
ss
a
ri
ly
re
fl
e
ct
d
if
fe
re
n
ce
in
a
b
so
lu
te
ch
a
n
g
e
b
e
ca
u
se
o
f
in
cl
u
si
o
n
o
f
co
va
ri
a
te
s
in
m
o
d
e
ls
te
st
e
d
.
¶V
a
lu
e
s
d
if
fe
r
fr
o
m
si
m
p
le
su
b
tr
a
ct
io
n
d
u
e
to
ro
u
n
d
in
g
.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 5 of 14
May-July 2008 by two of the authors (AS andUG) and
one researcher (JW).
Data analysis of interviews was based on the con-
stant comparative method,21 facilitated by the use of
NVivo software. For focus groups and ethnographic
field notes, simple coding procedures were used to
categorise the data thematically.
Quality of care/error rates in patients with acute
respiratory disease on medical wards
Using case note review, we assessed quality of care
using standards based on established guidelines wher-
ever possible. We reviewed case notes from patients
with similar clinical conditions across the SPI1 and
control hospitals so that we could compare like with
like. Case note review is resource intensive and thus
must be selective. We focused on patients aged over
65with acute respiratory disease (community acquired
pneumonia, exacerbation of asthma, or chronic
obstructive pulmonary disease) admitted to medical
wards (one in each participating hospital) (box 2).
The review assessed processes targeted by SPI1 (such
as quality of observations to detect deteriorating
patients) and those that might be expected to improve
if there was an overall shift in organisational systems
and culture toward patient safety (such as improved
medical histories).
Case notes from the 18 control and four SPI1 hospi-
tals were collected from two periods of six months,
which we termed epochs. Epoch 1 (October 2003 to
March 2004) was before the intervention and epoch 2
(October 2006 to March 2007) was after.
We aimed to analyse 100 sets of case notes fromeach
SPI1 hospital per epoch (800 in total) and 15 from each
control hospital per epoch (540 in total). This would
give 80% power to detect a 13 percentage point
improvement in error rates from a baseline of 70% at
P=0.05 (see full report for further details).6 For each set
of case notes, the admissions of interestwere photocop-
ied, anonymised, and digitised and the year of admis-
sion was removed to ensure blinding to epoch. These
processes were completed before reviewing. Review
was both explicit (criterion based) and implicit (holis-
tic) because each method identifies a different spec-
trum of errors.30
Criterion based review—Qualified pharmacists (MG
and BDF) conducted explicit reviews according to pre-
defined criteria relating to deterioration of the patient;
medical history taking; compliance with evidence
based care; and prescribing errors (table 4). To control
for any learning or fatigue effects, or both, in reviewers,
case notes were scrambled to ensure that they were not
reviewed entirely in series. Agreement on prescribing
error between observers35 was evaluated by assigning
one in 10 sets of case notes to both reviewers, who
assessed cases in batches, blinded to each other’s
assessments, but compared and discussed results after
each batch. Data were collected on the adequacy of
masking of patients’ names, hospital, and epoch. All
analyses were adjusted for patient level covariates of
age and sex. We used cubic polynomials in the time
of review to adjust for learning/fatigue effects in the
review process.
Holistic review—Holistic review was not part of the
original protocol (for either SPI1 or SPI2) but was car-
ried out after a suggestion by the late Vin McLoughlin
(a director of the Health Foundation) in November
Box 2: Rationale for focus on patients aged over 65 admitted with acute respiratory
disease
 It was important to focus on an issue where all four SPI1 hospitals would be
implementing a specific SPI intervention (intensive care was excluded partly for this
reason)
 There is a high incidence of comorbidities in people aged over 65, making this a high
risk and hence a potentially error-rich population in which an effective organisational
patient safety intervention might yield detectable improvements. Improving
recognition and response to acute deterioration was a specific target of the SPI (see
box 1), and patients admitted with acute respiratory disease are at high risk of such
deterioration2728
 There was evidence that monitoring and medication practice was suboptimal in NHS
hospitals, thus providing sufficient room for improvements to be detected with
samples of affordable size29
 A single set of case notes could be used to assess end points targeted by several SPI
interventions (see box 1), specifically including management of patients at risk of
deterioration and prescribing errors
Table 4 | Explicit case note review in phase one of Safer Patients Initiative (SPI1): areas of review, source of criteria, method for assessment of errors, and
relevant SPI target
Area of review Source of criteria How it was assessed Specific SPI goal
Clinical observations and signs
of patient deterioration
British Thoracic Society
(BTS)31 32
Completeness with which patients’ vital signs were recorded (table 5) evaluated on admission and then
for first and subsequent 6 hour time periods. Vital sign data recorded in case notes constituted
numerator, while all vital signs that should have been recorded constituted denominator
Yes
Quality of medical history
taking
Expert opinion for patient
admitted with acute
respiratory disease
11 items (table 8) constituting ideal history each marked as inquired into or not No
Compliance with evidence
based care specific classes of
patients
Expert opinions, BTS, or
British National Formulary
(BNF), or both as specified
Proportion of patients for whom urea and electrolytes, chest x ray, and full blood count ordered within 6
hours of admission (expert opinion)
No
Proportion of patients with pneumonia for whom CURB score was calculated (BTS, BNF) Yes
Proportion of patients with COPD and asthma receiving systemic steroids (BTS) No
Proportion of patients with asthma in whom peak flow was measured (expert opinion) No
Prevalenceofprescribingerrors Previously developed forms
based on BNF33
Errors were identified and categorised according to stage of drug use process.34 Denominator was
number of drugs used
Yes
CURB=confusion/urea/respiratory rate/blood pressure score; COPD=chronic obstructive pulmonary disease.
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2007 at a project progress meeting. A specialist in gen-
eral medicine (MC) holistically evaluated each set of
case notes to identify errors in the care of patients and
adverse events. To measure reliability between
observers,35 an experienced trainee in respiratory
medicine (TN) independently re-evaluated a subset of
these case notes (n=91). Error was defined, according
to Reason, as “a failure to complete a planned action as
it was intended or adoption of an incorrect plan.”36 The
results, adjusted for age and sex, are presented as the
average number of errors per 100 patients; a patient
could have more than one error. Errors were cate-
gorised as relating to diagnosis on admission; hospital
acquired infection; technical/management; medica-
tion/maintenance/test results; clinical reasoning; and
discharge information.37-41 Reviewers also gave an
overall rating of the quality of care.6
Outcomes
Adverse events—The holistic review of case notes identi-
fied adverse events related to healthcare, which were
reported as a rate of total adverse events per 100
patients. An adverse event was defined as “an unin-
tended injury or complication which results in disabil-
ity, death or prolonged hospital stay and which is
caused by healthcare management.”38 Reviewers clas-
sified adverse events (including those resulting in
death) by degree of preventability (on the balance of
probabilities). Adjustments weremade for age and sex.
Mortality—Overall adjusted (or crude) hospital mor-
tality rates for all four SPI1 hospitals were not available
because of difficulty accessing this information from
the non-English countries. Overall mortality was unli-
kely to be a useful measure for this study as it is an
insensitive marker of avoidable mortality,42 creating a
high risk of a false negative result in a study with only
four intervention hospitals.43 We therefore compared
mortality rates across epochs among patients in medi-
cal wards whose case notes had been included in the
case note review. Adjustments were made for age, sex,
and number of comorbidities.
Patients’ satisfaction—An emphasis on safety can
make staff and patients feel valued.44We used a survey
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Fig 2 | Correlation between knowledge and enthusiasm for
SPI1 among senior strategic hospital staff (some points
represent results for more than one interviewee)
Table 5 | Vital signs and routine investigations before (epoch 1) and after (epoch 2) phase one of Safer Patients Initiative
(SPI1). Figures are percentage compliance (binomial standard error (SE)) and odds ratios
Control hospitals SPI1 hospitals OR (99% CI), P value
Epoch 1
(n=236)
Epoch 2*
(n=240)
Epoch 1
(n=381)
Epoch 2*
(n=380) Changes in controls Effect of SPI1†
On admission
Temperature 98 (1) 99 (1) 99 (1) 99 (1) 5.1 (0.3 to 89.5), 0.144 0.2 (0.01 to 8.5), 0.289
Respiratory rate 96 (1) 99 (1) 91 (2) 98 (1) 4.7 (0.6 to 36.5), 0.052 1.5 (0.2 to 16.0), 0.677
Cyanosis/oxygen
saturation
99 (1) 99 (1) 98 (1) 99 (1) 1.7 (0.2 to 18.2), 0.578 2.7 (0.1 to 55.2), 0.385
Confusion/mental state 58 (3) 65 (3) 67 (2) 69 (2) 1.2 (0.7 to 2.1), 0.307 1.2 (0.6 to 2.6), 0.437
Pulse 99 (1) 99 (1) 99 (1) >99 (<1) 3.3 (0.2 to 68.7), 0.306 0.5 (0.01 to 23.7), 0.614
Blood pressure 99 (1) 99 (1) 99 (1) >99 (<1) 3.3 (0.2 to 68.7), 0.306 0.5 (0.01 to 23.7), 0.614
At 6 hours
Temperature 62 (3) 74 (3) 76 (2) 86 (2) 1.7 (1.0 to 2.9), 0.008 1.0 (0.5 to 2.2), 0.976
Respiratory rate 44 (3) 73 (3) 43 (3) 82 (2) 3.6 (2.1 to 6.2), <0.001 2.0 (1.0 to 4.2), 0.015
Pulse 67 (3) 77 (3) 83 (2) 88 (2) 1.7 (1.0 to 3.0), 0.012 1.0 (0.4 to 2.3), 0.973
Oxygen saturation 61 (3) 75 (3) 77 (2) 88 (2) 1.9 (1.1 to 3.3), 0.002 1.3 (0.6 to 2.8), 0.425
At 12 hours
Temperature 59 (3) 70 (3) 71 (2) 82 (2) 1.8 (1.0 to 3.0), 0.005 1.3 (0.6 to 2.8), 0.314
Respiratory rate 40 (3) 69 (3) 37 (3) 78 (2) 3.7 (2.2 to 6.2), <0.001 2.1 (1.0 to 4.3), 0.008
Pulse 62 (3) 74 (3) 75 (2) 83 (2) 1.9 (1.1 to 3.2), 0.002 1.2 (0.5 to 2.5), 0.618
Oxygen saturation 56 (3) 73 (3) 64 (3) 82 (2) 2.3 (1.4 to 3.9), <0.001 1.4 (0.7 to 2.9), 0.234
Routine investigations
Urea and electrolytes >99 (<1) 99 (1) 99 (1) 99 (1) 0.6 (0.02 to 14.1), 0.665 0.8 (0.02 to 39.5), 0.865
Chest x ray 97 (1) 98 (1) 95 (1) 94 (1) 2.4 (0.5 to 11.8), 0.164 0.5 (0.1 to 3.0), 0.291
Full blood count 99 (1) 98 (1) 99 (1) 98 (1) 1.2 (0.1 to 10.5), 0.789 0.2 (0.01 to 5.4), 0.223
*After intervention.
†OR >1 favours SPI1.
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based on the questionnaire used in the National NHS
Acute Inpatient Survey in England (www.nhssurveys.
org) to obtain evidence of such a “halo effect” on
patients’ experiences. The dates of the surveys of
patients were aligned with the dates of staff surveys.6
Five scores were identified for analysis: three related
to overall satisfaction scores and two to cleanliness.
Data in the control arm were available only at the
level of the organisation (hospital), not at the level of
the individual clinical directorate (medicine, surgery,
etc). Thus the analysis was conducted at the organisa-
tional level throughout. In the SPI1 arm, organisation
level scoreswere formed by averaging all respondents’
scores in each hospital.
Statistical methods
We used generalised linear mixed models for formal
statistical analyses. Fixed effects were included for the
difference in levels before the intervention between
control and SPI1 hospitals (“baseline comparisons”);
the change over time in control hospitals between the
period before (epoch 1) and after (epoch 2) the inter-
vention; and the effect of SPI1, interpreted as the dis-
crepancy between the temporal changes experienced
over the two epochs in the control and SPI1 hospitals.
The impact of intraclass correlation in before and after
studies is lower than for cross sectional studies.18 45
Nevertheless, we took into account the effect of hospi-
tal level clustering by including randomeffects for each
hospital.
We used logistic models for binary responses; Pois-
son models for adverse events and general care errors;
negative binomial models for medication errors (per
recorded prescription); and normal models in all
other cases. No adjustments were made for multiple
comparisons, but we used 99% confidence intervals
throughout and significance was set at P<0.01. Agree-
ment between observers was tested with the intraclass
correlation coefficient for rating scales and the κ statis-
tic for dichotomous judgments. All models were fitted
in Stata v10.
RESULTS
Senior/strategic staff interviews
Interviews with senior/strategic hospital staff in the
SPI1 hospitals showed that they were mainly positive
about SPI1 and had considerable enthusiasm for the
initiative and its principles. Only seven of the 60
participants were unable to describe SPI1 accurately
or in detail.8 Even though there was a broadly shared
understanding of the programme’s theory of change
(what the intervention was intended to achieve and
with what methods), there was less evidence of an
explicit and shared organisational theory of change
(what was needed to make the programme work at an
organisational level and how programme implementa-
tion could be optimised). Despite their enthusiasm,
hospital staff members expressed multiple concerns
about the ambitious reach of the programme, whether
resourceswould be equal to the demands, andwhether
resistance might be encountered at the “sharp end”46
where staff care for patients. Strategies for overcoming
such difficulties were not clear in the accounts of stake-
holders.
The quantitative analysis found that 73% scored
above 5 (out of 10) on the knowledge scale and 83%
scored above 5 (out of 10) on the enthusiasm scale
(fig 2). Correlations between knowledge and enthu-
siasm across the three raters were 0.61, 0.69, and
0.91. Reliability between raters was medium to high,
with intraclass correlations of 0.55 for knowledge and
0.65 for enthusiasm.
Staff survey
There was no significant difference in response rates
between control and SPI1 hospitals at baseline, and
the hospitals were broadly similar with respect to mor-
ale, attitudes, and culture of the hospital staff at base-
line. Table 3 shows the changes in control and SPI1
hospitals on each of 11 scores, along with the differ-
ences between groups. The difference was significant
for only one of the 11 scores (organisational climate)
(P<0.01), favouring the SPI1 hospitals over controls.
There was a modest effect size for the difference in
change between the control and SPI1 hospitals after
covariates were taken into account: 0.08 points on a 5
point scale where there was a range at baseline of 0.50
points between hospitals.
Qualitative study
The focus groups in fourmedical wards across the four
sites agreed that the senior staff members in the hospi-
talswere committed and enthusiastic about SPI1,made
a significant strategic contribution, gave weight to the
initiative, and generally set a good example for staff.
Table 6 | Compliance with particular standards (such as use of steroids when indicated) before (epoch 1) and after (epoch 2)
phase one of Safer Patients Initiative (SPI1). Figures are numbers (percentage, SE) and odds ratios for effect of SPI1
Control hospitals SPI1 hospitals
OR (99% CI)†, P valueEpoch 1 Epoch 2* Epoch 1 Epoch 2*
Asthma or COPD: given systemic steroids within 24 hours 129 (88, 3) 135 (93, 2) 224 (91, 2) 199 (88, 2) 0.7 (0.2 to 2.9), 0.500
Asthma peak flow record‡ 34 (79, 7) 29 (83, 7) 78 (82, 4) 37 (65, 8) 0.6 (0.04 to 8.2), 0.570
Pneumonia: CURB score recorded in notes 102 (2, 1) 111 (23, 4) 170 (2, 1) 189 (9, 2) 0.3 (0.02 to 3.4), 0.173
COPD=chronic obstructive pulmonary disease; CURB=confusion/urea/respiratory rate/blood pressure score.
*After intervention.
†OR >1 favours SPI1.
‡Item with significant between hospital components of variation within arms of study (P<0.01).
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“If these guys aren’t behind it very quickly your clin-
ical directors and . . . other directors, you know [other]
senior people start to fall by the wayside and so I think
that’s absolutely paramount having the top guys lead-
ing the way, so I think that has been one of the big
successes.”
The involvement of the IHI in SPI1 was seen as cru-
cial in lending credibility and support to the initiative
and was much valued as a source of knowledge and
expertise.
Ethnographic observations suggested that medical
wardswere pressurised settings, often copingwithmul-
tiple demands and limited resources.47 The impact of
SPI1 at the sharp end of medical wards was mostly dif-
ficult to detect, except in relation to improvedmonitor-
ing of patients’ vital signs and use of early warning
score track-and-trigger systems to detect and respond
to possible deterioration.
Despite the enthusiasm and support at the strategic
level or “blunt end,” medical ward staff, for the most
part, tended either to know relatively little about SPI1
procedures, practices, and principles, or viewed them
as handed down (top down) rather than something
they were involved in developing (bottom up). There
was little evidence that frontlinemedicalward staff per-
ceived a sense of ownership over the initiative. The
perception existed among some that SPI1 had allowed
a small number of people to become an elite group
with enhanced career prospects, while others were
left feeling excluded.
“SPI was a select group of twenty people . . . you’re
starting off in small areas and of course the by-product
of that is that you’ve got a small group dealing with
those small areas so there is, although we may not
like it, there is a perception in some parts of the orga-
nisation that SPI is a, an elite entity.”
The gap between the strategic level view and what
was happening at the sharp end was evident in several
different ways. For example, “leadership walk rounds”
were discussed enthusiastically in the leadership focus
groups, but some staff members at the sharp end
thought that the process was disappointing and might
even have undermined SPI1 because it sometimes
seemed to show a failure to connect senior manage-
ment with the wards in meaningful ways.
“Well he came around and spoke to a few people and
just asked about any concerns. He said he was inter-
ested to know how the nursing staff felt and he wanted
to know one thing that he could take back to the rest of
the board about any issues that nursing staff had.After-
wards they sent a letter to say thanks but you never
hear any . . . well we haven’t heard anything more
than that so.”
Several PDSA “success stories”were reported in the
focus groups. Few of the frontline ward staff members
interviewed, however, seemed aware of PDSA cycles.
Somewhere between the blunt end and the sharp end,
the model of participative engagement on which SPI1
was based had got rather lost, at least in relation to
medical wards. There were several important influ-
ences that determined the extent to which SPI1 inter-
ventions became embedded on these wards. One
example was intensity of the “dose” of SPI1 given to
the wards. The activities of SPI1 change agents were
dispersed throughout hospitals, and they might have
focused their efforts on the more well defined clinical
areas (such as the intensive care unit) that were the sub-
ject of clinical processes targeted by SPI1.
“The ward aspect was one of themore difficult areas to
implement because it wasn’t as sort of specific, as con-
fined, whereas the other areas perhaps were confined
to theatres or ICU. [The ward] was much more . . .
nebulous and covered a much bigger area . . . than
perhaps other parts of the SPI.”
A further issue was legitimacy. Sometimes staff sim-
ply did not see particular interventions as being scien-
tifically legitimate.
“Something that appears on the surface very simple,
like the definition of a surgical infection, caused an
absolute riot.”
Scientific legitimacy debates were, perhaps para-
doxically, exacerbated by the use of PDSA cycles.
Some clinical staff members reported seeing the run-
chart data collected during the cycles as unreliable and
lacking in credibility and therefore as not providing
enough of a prompt for change. Claims of problematic
evidence, however, might have been used strategically
as a means of resisting change and reinforcing inertia.
Legitimacy issues also arose when staff members did
not recognise that the problem being tackled was a
“real” one requiring a particular response, or they did
not consider that the resources that would be required
to implement the intervention were legitimate in light
of other priorities and pressures. We observed further
barriers to adopting safety initiatives, including the
instability of teams caused by rotating and agency
staff, meaning it was difficult to sustain a collective
knowledge and faith in SPI1 over time.
Positive impacts of SPI1 included increasedmanage-
rial recognition and focus on patient safety and the pro-
motion of a systematic approach. One of the major
Table 7 | Analysis of prescribing errors before (epoch 1) and after (epoch 2) phase one of
Safer Patients Initiative (SPI1)
Control hospitals SPI1 hospitals
Epoch 1 Epoch 2* Epoch 1 Epoch 2*
No of patients† 233 239 381 378
No of prescriptions 5482 6207 10664 11538
Prescriptions per patient 23.5 26.0 28.0 30.5
Total No of errors 596 564 1157 1530
Error rate (SE)‡ 0.14 (0.02) 0.11 (0.01) 0.15 (0.02) 0.15 (0.01)
*After intervention.
†With medication charts available for review.
‡Adjusted for date of review.
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lessons learnt was the scale of resources and organisa-
tional support required to make patient safety initia-
tives work. There was a perception that hospitals had
underestimated this and been too ready to assume that
something that worked in a defined clinical area (such
as intensive care units) would easily transfer to other
environments or would spontaneously spread. Hospi-
tals reported that they had begun to devise strategies
for future implementation, which included engaging
senior clinicians and encouraging local ownership.
Quality of care/error rates in patients with acute
respiratory disease on medical wards
Explicit review of case notes
The smallest SPI1 hospital in our sample could not
provide the target numbers of case notes, leading to a
slight shortfall in the intended SPI1 sample size of 400
sets of case notes in each epoch: 381 in epoch 1 and 380
in epoch 2. Control hospitals yielded 236 sets of case
notes in epoch 1 and 240 sets in epoch 2. Baseline com-
parisons across all 1237 sets showed no significant dif-
ferences between the control and SPI1 hospitals for
any of the explicit review measures (table 4) assessed
against the predetermined criteria.
Compliance in recording patients’ observations at
both six and 12 hours after admission improvedmark-
edly between the two epochs, and this was significant
for all but one of eight possible items. Both control and
SPI1 hospitals improved, though the improvement
was greater in SPI1 hospitals (table 5); this difference
in difference was significant only for the recording of
respiratory rate at 12 hours. There was also a consider-
able increase over time in use of theCURB (confusion/
urea/respiratory rate/blood pressure) score in patients
with pneumonia, but these differences were not signif-
icant between control and SPI1 hospitals, and the point
estimate favoured controls (table 6).
There were many prescribing errors, but these were
mostly minor (table 7). There were no significant
effects of SPI1 either over time or in favour of SPI in
quality of prescribing (error rate ratio (estimated from
population averaged negative binomialmodel) 1.2, 0.9
to 1.8; P=0.138).
The quality of observations, risk assessment, and
prescribing were SPI1 targets (box 1), but we also
sought evidence of a “halo effect” that might be evi-
dence of a general strengthening of the system. There
was no evidence of improvement in adherence to var-
ious tenets of safe evidence based practice (table 6)
either over time or in SPI1 hospitals in particular.
Compliance with certain standards (such as use of ster-
oids when indicated) was already high (over 85%) at
baseline in both sets of hospitals, leaving little room
for further improvement. The quality of history taking
remained stable over time in both control and SPI1
hospitals (table 8).
A comparison of the prescribing error results
showed substantial35 agreement between the two
observers, with a κ of 0.71 and 0.70 in epochs 1 and
2, respectively. For some items—notably prescribing
errors (table 7) and recording of exercise tolerance
and chest pain (table 8)—the time in the sequence
when the review of the case notes was conducted
made a significant contribution to the recorded out-
come. The propensity to record prescribing error first
improved (taken as learning) and then declined (taken
as fatigue). Adjustment for these effects was made in
the analysis of these and all other items (see full report
for further information on tests for homogeneity of end
points among control and SPI1 hospitals, and effects of
patient age on the quality of care6). Despite masking of
all case notes in the hospital records department, and
again at the Birmingham “centre” (see methods), the
reviewer was able to discern the patient’s name in 4%
Table 8 | Medical history taking (% of patients asked required questions) before (epoch 1) and after (epoch 2) phase one of
Safer Patients Initiative (SPI1) and effect of SPI. Figures are percentages (binomial standard errors (SE)) and odds ratios
(99% confidence intervals) and P values for effect of SPI1
Control hospitals SPI1 hospitals
OR (99% CI)†, P value
Epoch 1
(n=236)
Epoch 2*
(n=240)
Epoch 1
(n=381)
Epoch 2*
(n=380)
Duration of “presenting” symptom 95 (2) 95 (2) 95 (1) 96 (1) 1.6 (0.4 to 6.9), 0.414
Normal exercise tolerance 33 (3) 35 (3) 33 (2) 37 (3) 1.5 (0.7 to 3.0), 0.178
Presence/absence shortness of breath 90 (2) 92 (2) 93 (1) 94 (1) 0.9 (0.3 to 3.1), 0.843
Presence/absence orthopnoea 28 (3) 29 (3) 24 (2) 20 (2) 1.0 (0.5 to 2.2), 0.966
Presence/absence cough 90 (2) 90 (2) 85 (2) 89 (2) 1.9 (0.7 to 5.3), 0.129
If cough present, was it productive 83 (3) 86 (2) 82 (2) 88 (2) 1.3 (0.5 to 3.3), 0.453
History of smoking taken 76 (3) 80 (3) 80 (2) 82 (2) 0.8 (0.4 to 1.9), 0.519
Presence/absence of haemoptysis 24 (3) 26 (3) 26 (2) 27 (2) 0.9 (0.4 to 1.9), 0.769
Chest pain (of any type) 61 (3) 69 (3) 75 (2) 72 (2) 0.7 (0.3 to 1.5), 0.230
Occupation/previous occupation 40 (3) 38 (3) 64 (3) 64 (3) 1.1 (0.6 to 2.2), 0.622
Pets at home 3 (1) 3 (1) 2 (1) 1 (1) 0.6 (0.1 to 6.1), 0.571
% over all items 57 59 60 61 —
*After intervention.
†OR >1 favours SPI1.
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(42) of cases; hospital of origin in 1% (11) of cases; and
epoch in 14% (158) of cases.
Holistic review of case notes
In the four SPI1 hospitals, 390 and 381 sets of case
notes from epoch 1 and epoch 2, respectively, were
holistically reviewed. For the 18 control hospitals,
numbers were 243 and 246, respectively (range 8-15
cases per hospital). The total number of case notes
(1260) is slightly different to the number in the explicit
review because not all notes had been sent for both
types of review when the study “closed.” Both
reviewers assessed 91 sets of case notes; measures of
reliability between them were, as expected for holistic
reviews,30 low (κ=0.15, SE 0.08).
A total of 425 errors were identified. The most com-
mon categories of errors related to diagnosis, assess-
ment, or admission or to poor clinical reasoning.
From epoch 1 to 2, error rates declined from 44.4 to
42.3 in control hospitals and from 29.7 to 24.4 in the
SPI1 hospitals. The difference in changes across con-
trol and SPI1 hospitals was not significant (rate ratio
0.87, 99% confidence interval 0.52 to 1.44; P=0.48).
Outcomes
Adverse events
The holistic review of the 1260 case notes identified 56
adverse events across all epochs and hospitals, giving
an overall adverse event rate of about four per 100
patients treated. Agreement between raters in identifi-
cation of adverse events was somewhat higher than
agreement in identification of errors by holistic review
(κ=0.25). The adverse event rate increased from 2.9 to
4.8 per 100 patients in control hospitals and declined
from 6.2 to 3.7 among SPI1 hospitals. This difference
in changes across control and SPI1 hospitals was not
significant (rate ratio 0.40, 0.09 to 1.84; P=0.12).
In about a quarter (16) of the adverse events, there
existed strong or certain evidence that the event was
preventable (box 3). At around 1.3% (16/1260), this
is a somewhat lower rate of preventable adverse events
than reported for hospital inpatients elsewhere.40
Mortality
Themortality rate among patients admitted tomedical
wards was high, at over 14% (178 deaths across 1237
sets of case notes included in the explicit review), but
there were no significant differences between control
and SPI1 hospitals in the adjusted mortality rates. The
baseline comparisons showed no significant differ-
ences between control and SPI1 hospitals nor was
there significant evidence of temporal change in the
control hospitals (table 9). When we adjusted figures
for age, sex, and number of comorbidities in the analy-
sis of mortality rates the odds ratios were 1.9 (99% con-
fidence interval 0.6 to 5.6; P=0.149) for the baseline
comparison, 1.4 (0.7 to 2.9; P=0.274) for the change
in control hospitals, and 0.5 (0.2 to 1.4; P=085) for the
effect of SPI1. There was no significant effect of sex or
number of comorbidities on mortality, but the odds of
death increased by 8% (5% to 11%) per year of patient
age (P<0.001). Few of the deaths were attributable to
error. In two cases, the reviewer thought that the death
was definitely causedby the error (untreateddocumen-
ted hyperkalaemia, failure to recognise adrenal crisis)
and in two further cases that it wasmore likely than not
that death could have been averted (wrong choice of
antibiotic, insulin overdose).
Table 9 | Mortality rates before (epoch 1) and after (epoch 2) phase one of Safer Patients
Initiative (SPI1)
Control hospitals SPI1 hospitals
Epoch 1 Epoch 2* Epoch 1 Epoch 2*
No of Patients 236 240 381 380
Deaths 27 39 63 49
% Mortality (SE) 11.4 (2.1) 16.3 (2.4) 16.5 (1.9) 12.9 (1.7)
Mean (SD) age (years) 77.6 (7.6) 79.7 (7.7) 77.4 (7.6) 78.2 (8.0)
% women 58.5 52.1 50.4 51.8
Mean No of comorbidities 2.8 3.1 3.3 3.8
*After intervention.
Box 3: Preventable adverse events identified as being strongly* or certainly preventable
in the 1260 case notes reviewed in the holistic review
Epoch 1
Control hospitals
 Patient given oxygen and became unrousable from CO2 retention, required admission
to intensive care unit
SPI1 hospitals
 Patient lost consciousness because of hypoglycaemia caused by overdose of insulin to
control hyperkalaemia (patient died)
 Supraventricular tachycardia in patient with untreated hypokalaemia (patient died)
 Wrong choice of antibiotic for severe community acquired pneumonia (patient died)
 Patient’s breathlessness deteriorated because nurses omitted scheduled use of
nebuliser
 Patient sent home with severe uninvestigated anaemia†
 Patient started on treatment for hyperthyroidism, despite equivocal test result (and in
wrong dose)
 Bronchospasm could have been avoided or lessened had β blocker been stopped
Epoch 2
Control hospitals
 Patient lost consciousness because of hypoglycaemia caused by overdose of insulin to
control hyperkalaemia*
 Delay in administration of vitamin K leading to haematoma
 Patient’s breathlessness increased, requiring transfer to high dependency unit, after
failure to administer prescribed antibiotics
SPI1 hospitals
 Patient’s collapse caused by adrenal crisis because corticosteroids were not
prescribed for patient with known Addison’s disease (patient died)
 Failure to treat MRSA; general practitioner not informed on discharge. No absolute
evidence of harm but high risk
 Severe anaemia not investigated and general practitioner not informed†
 Bronchospasm could have been avoided or lessened had β blocker been stopped
 Failure to inform general practitioner of the risk of CO2 retention†
*More likely than not (>50%) on balance of probabilities.
†No absolute evidence of harm in these cases but patients were discharged in clear danger and this influenced reviewer.
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Patients’ satisfaction
The response rate for the first survey was 54% (1961/
3624) in the four SPI1 hospitals; for the second it was
51% (1720/3397). In the 18 control hospitals there was
a greater fall, from 63% (9563/15274) to 56% (8590/
15300). At baseline there were no significant differ-
ences between control and SPI1 hospitals on any of
the scores. Only one of the patient satisfaction scores
(cleanliness of bathrooms) showed a significantly dif-
ferent change (favouring SPI1) (table 10).
DISCUSSION
Main findings
Phase one of the Safer Patients Initiative (SPI1) was
generally greeted enthusiastically at the strategic level
(blunt end) in participating hospitals. Ethnographic
observations and interviews, however, suggested that
staff at the sharp end of medical wards generally had
only a vague idea of the intervention, and that, with the
exception of patientmonitoring, few had direct experi-
ence of most of its components. Only one of the 11
dimensions on the staff survey changed significantly
between groups; this occurred on an item relating to
organisational climate, which favoured the SPI. Quan-
titative evaluation showed a significant effect in favour
of SPI1 in respect of only one clinical process. This
exception was in relation to the aim of improving
observation of acutely ill patients, where recording of
respiratory rate improved significantly more in SPI1
than in control hospitals. This quantitative finding
was consistent with the qualitative observations.
During the study there was a general improvement
in the quality of the monitoring of vital signs among
both control and SPI1 hospitals; there was improve-
ment in all eight of the required measurements of
vital signs over the first 12 hours after admission (and
this was significant in all but one case). The magnitude
of the improvement in monitoring respiratory rate
from before to after the intervention was greater than
the magnitude of the difference between control and
SPI1 hospitals. Likewise there was a sharp improve-
ment over time in use of formal risk scoring for patients
with pneumonia. These findings are all consistent with
a general (temporal) improvement in the quality of
monitoring for sick patients in the NHS over the
study period.
We observed several clinical processes that were not
specific SPI1 targets but might have been expected to
improve if the overall goal of strengthening the system
and achieving cultural and organisational realign-
ments around safety had been achieved on medical
wards. There was no significant difference between
control and SPI1 hospitals over time. For some mea-
sures—such as use of corticosteroids in patients with
chronic obstructive pulmonary disease and asthma—
practice was already good at baseline and there was
little room for further improvement. There was, how-
ever, also no change in other measures of quality of
care, even when there was greater room for improve-
ment. The holistic review corroborated findings from
the criterion based explicit review, showing no consis-
tent trends in either errors or adverse events inmedical
wards treatingpatientswith acute respiratorydisease in
control versus SPI1 hospitals.
Strengths and weaknesses
Our study had several strengths, including use of a pre-
defined protocol, selected competitively, for evaluat-
ing SPI1. We quantified safety practices and used
independent reviewers who made observations across
multiple hospitals. Breaking the link between reviewer
and hospital removes vested interest and ensures that
anymeasurement error is systematic, thereby reducing
risk of bias in comparisons between institutions.
Reviewers were masked (as further insurance against
observer bias), and we quality assured the masking
process. We measured learning/fatigue effects (not
just variation between observations)30 to ensure that
comparisons were not biased over time. Qualitative
and quantitative observations across the different
levels of hospitals enabled “triangulation”48 of data col-
lection and interpretation. We used a before and after
controlled design and “difference in difference”
approach to quantitative measurements.15 With some
notable exceptions49 50 most quality improvement
reports lack contemporaneous controls, thus denying
Table 10 | Patient survey scores* in control and SPI1 hospitals before (survey 1) and after (survey 2) phase one of Safer Patients Initiative (SPI1)
Control hospitals SPI1 hospitals
Range at
baseline
Effects of SPI1‡
(99% CI), P value
No of
patients
Survey
1
Survey
2†
Absolute
%change
No of
patients
Survey
1
Survey
2†
Absolute
%change
Overall, how would you rate the care you
received?
9209 79 77 −2 2325 77 76 −1 71-83 1 (−1 to 3), 0.330
Overall, did you feel you were treated with
respect and dignity while youwere in hospital?
9213 89 87 −1 2370 88 86 −2 84-91 −1 (−2 to 1), 0.269
How would you rate how well doctors and
nurses worked together?
9161 78 76 −2 2360 76 75 −1 72-82 1 (−1 to 3), 0.135
In your opinion, how clean was hospital room
or ward that you were in?
9323 82 80 −1 2395 79 79 0 71-89 1 (−1 to 4), 0.288
Howcleanwere toilets andbathroomsthat you
used in hospital?
9147 79 77 −2 2302 74 76 1 69-86 3 (0 to 6), 0.009
*Mean values of the five survey scores in control and SPI1 hospitals for first and second patient surveys, rated between 0-100.
†After intervention
‡Values >1 favour SPI1.
RESEARCH
page 12 of 14 BMJ | ONLINE FIRST | bmj.com
the ability to be confident in determining whether any
changes can be attributed to the intervention.
These strengthsmean that this evaluation adds to the
science of evaluating large scale, complex quality
improvement interventions that defy rigorous assess-
ment with single method or single measure designs.
Our approach dealt with the problems of data quality
and other biases associated with using hospitals’ own
SPI1 run-charts, which are not designed for research
purposes. A separate study has shown that data are
not collected in a consistently defined way and tend
to have missing values.51
One limitation of our study is that it was non-rando-
mised. Results might have been biased against SPI1
because SPI1 hospitals might have had less room for
improvement, and controls might have had higher
than average performance, particularly as half were
also selected as future SPI2 intervention sites. The
staff survey and explicit review, however, showed simi-
lar performance at baseline, while adverse events and
error rates detected on holistic review were equivocal
(favouring the control hospitals in one domain and the
SPI1 hospitals in another).
Results might have been biased in favour of SPI1
because SPI1 sites were selected, not chosen at random
(the reverse of the possible biasmentioned above), and
agreement to participate in the evaluation could have
had a differentially motivating effect in SPI1 hospitals
than in control hospitals (a form of the Hawthorne
effect that could not be avoided by randomisation).
These potential biases against controls would have
been scientifically more worrisome had the results
not been mostly null.
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